Pharmacies get a delay on track-and-trace regs; Drugmakers assess supply issues in Greece;

> Pharmacies have won a four-month delay, to Nov. 1, 2015, for meeting new regulations for product tracing that were to take effect Wednesday. Story

> Supreme Court ruling raises questions about warrantless inspections of manufacturing sites. Blog post

> Drugmakers are trying to decide how to avoid shortages in Greece if the debt problems are not worked out. Story

> Celgene ($CELG) is buying a the complex in Summit, NJ vacated by Merck ($MRK), a 1.3 million-square-foot site that includes manufacturing capabilities and warehouses along with R&D facilities and administrative space. Story

> A California man has pleaded guilty to selling counterfeit Viagra and Cialis in the U.S. Release

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.